Table 5

Meta-regression exploring the impact of trial-level characteristics on the effects* of the intervention on the rate of falls and risk of one or more falls and risk of recurrent falls

Variable tested in meta-regressionTrials, nCoefficient (95% CI)Reduction in I2 (%)
Rate of falls (I2 in original meta-analysis=90.1%)
Trial design
Sample size†20/201.00 (1.00 to 1.00)−0.2
Less than 20% missing outcome data12/201.03 (0.68 to 1.54)0.7
Comparator usual care only15/200.66 (0.42 to 1.05)0.6
Participant characteristics
Average age >75 years14/201.11 (0.72 to 1.69)−0.5
Selected as high risk of falls14/200.89 (0.34 to 2.33)−0.1
Intervention components
Included NICE-recommended components17/202.37 (1.01 to 5.56)0.2
Actively provided treatment to address fall-related risk factors14/200.95 (0.63 to 1.45)−0.8
Adherence was assessed15/200.82 (0.28 to 2.44)−0.8
Risk of sustaining one or more falls (I2 in original meta-analysis=55.8%)
Trial design
Sample size†30/301.00 (1.00 to 1.00)1.3
Less than 20% missing outcome data15/300.98 (0.83 to 1.17)−1.5
Comparator usual care only25/300.94 (0.69 to 1.26)0.1
Participant characteristics
Average age >75 years20/300.96 (0.79 to 1.16)−0.7
Selected as high risk of falls19/300.89 (0.51 to 1.56)−0.6
Intervention components
Included NICE-recommended components25/300.98 (0.67 to 1.44)−1.3
Actively provided treatment to address fall-related risk factors17/300.94 (0.80 to 1.11)−0.2
Adherence was assessed20/301.19 (0.67 to 2.13)−1.0
Risk of sustaining recurrent falls (I2 in original meta-analysis=46.0%)
Trial design
Sample size†15/151.00 (1.00 to 1.00)0.6
Less than 20% missing outcome data7/151.31 (0.66 to 2.60)−0.7
Comparator usual care only12/150.94 (0.34 to 2.59)−4.4
Participant characteristics
Average age >75 years10/150.94 (0.52 to 1.72)−4.2
Selected as high risk of falls10/151.13 (0.33 to 3.95)1.1
Intervention components
Included NICE-recommended components13/151.01 (0.18 to 5.46)−4.1
Actively provided treatment to address fall-related risk factors10/150.78 (0.39 to 1.56)−1.0
Adherence was assessed11/150.89 (0.19 to 4.06)−6.8
  • *Associated with a greater fall prevention effect.

  • †Included as continuous variable.

  • NICE, National Institute for Health and Care Excellence.